The Founders
A Decade of Experience
Our co-founders share a 20-year relationship and 10 years of hands-on experience in health and medical devices, at times as collaborators, at times as competitors. They held roles ranging from clinical specialist to general manager. The weight of that experience is on the venous side. They worked on the devices used in varicose vein procedures. On the arterial side, they brought atherectomy, pharmacomechanical thrombectomy, PTA balloon, and carbon-dioxide angiography systems to market.
After 10 years focused on treatment, they turned their attention to what they had long seen as a missing piece: long-term health. The result is ARCH, a patented, one-of-a-kind circulatory health technology. ARCH is not a continuation of those devices. It is not a medical device, it does not treat anything, and it was designed for the hours you spend sitting still.
State Recognition
Backed by TÜBİTAK
In December 2024, we became a TÜBİTAK-supported venture, receiving both the Excellence Seal and direct state investment from Turkey’s national science and technology authority. This recognition confirms the scientific rigor and real-world potential behind what we’re building.
Academic Ecosystem
Rooted in Turkey’s Top Universities
We operate within the ecosystems of Boğaziçi University and Istanbul Technical University, two of Turkey’s most established and respected academic institutions. As members of their incubation centers and technoparks, which admit only a competitive few, we operate at the center of Turkey’s innovation infrastructure.
We took the stage at BigBang Startup Challenge, one of Turkey’s largest entrepreneurship platforms, winning $65,000. We are also a member of ITU Çekirdek, one of the world’s leading university-based accelerator programs.
View ARCH on BigBang Startup Challenge
Global Stage
Featured at CES
Earlier this year, we presented ARCH at CES, the world’s foremost technology showcase, introducing our product to the global technology ecosystem. Presenting alongside some of the world’s most innovative companies confirmed something we already believed: this problem isn’t unique to Turkey, and the product is ready for a global audience.
